Share：
Share this content in WeChat
X
[Chinese][PDF]68878
• Review •
Advance in MR imaging for cerebral oligodendroglial tumor
FANG Jing-qin  KANG Hou-yi  ZHANG Wei-guo 

DOI:10.3969/j.issn.1674-8034.2011.02.013.


[Abstract] Brain oligodendroglia tumor is the second most common glioma in central nervous system which has distinct molecular biologic and radiologic characteristic. MR spectroscopy, perfusion-weighted imaging, diffusion weighted imaging and susceptibility-weighted imaging, could reflect tumorous metabolism, hemodynamics and cellularity information and is superior to conventional MR imaging in preoperative diagnosis, classification and postoperative prognostic evaluation for brain glioma. In addition, the MRI characteristic of oligodendroglial tumor is associated with its biological features, that is to say MRI could reveal the tumorous gene type, In this article, we review the MR imaging for brain oligodendrogilal tumor, hoping to improve the preoperative diagnostic and grade level of brain oligodendroglial tumor.
[Keywords] Brain；tumor；Oligodendroglial tumor；Magnetic resonance imaging

FANG Jing-qin Department of Radiology, Research Institute of Surgery, Daping Hospital, the Third Military Medical University, Chongqing, 400042, China

KANG Hou-yi Department of Radiology, Research Institute of Surgery, Daping Hospital, the Third Military Medical University, Chongqing, 400042, China

ZHANG Wei-guo* Department of Radiology, Research Institute of Surgery, Daping Hospital, the Third Military Medical University, Chongqing, 400042, China

*Correspondence to: ZHANG WG, E-mail: wguo.zhang@gmail.com

Conflicts of interest   None.

Received  2010-12-22
Accepted  2011-02-06
DOI: 10.3969/j.issn.1674-8034.2011.02.013
DOI:10.3969/j.issn.1674-8034.2011.02.013.

[1]
Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol, 2005, 109(1): 93-108.
[2]
Coons SW, Johnson PC, Scheithauer BW, et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer, 1997, 79(7):1381-1393.
[3]
Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neurooncology. J Neuropathol Exp Neurol, 2003, 62(2):111-126.
[4]
Blakeley J, Grossman S. Anaplastic oligodendroglioma. Current Treatment Options in Neurology,2008,10(4): 295-307.
[5]
张伟国.脑胶质瘤MRI诊断进展-基于脑胶质瘤生理代谢特征的MRI成像.第三军医大学学报,2010,32(20):2153-2157.
[6]
吴雪斌,张伟国,陈金华,等.脑胶质瘤MR灌注成像与肿瘤微血管特征的相关性研究.临床放射学杂志,2010, 29(12):4-8.
[7]
Haris M, Husain N, Singh A, et al. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth gactor,microvascular density, and grading of astrocytoma. J Comput Assist Tomogr, 2008, 32(6): 955-965.
[8]
Spampinato MV, Smith JK, Kwock L, et al. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol, 2007, 188(1):204-212.
[9]
Murakami R, Sugahara T, Nakamura H, et al. Malignant Supratentorial Astrocytoma Treated with Postoperative Radiation Therapy: Prognostic Value of Pretreatment Quantitative Diffusion-weighted MR Imaging. Radiology, 2007, 243(2): 493-499.
[10]
Lee EJ, Lee SK, Bae JM, et al. Preoperative grading of presumptive low-grade astrocytomas on MR Imaging: diagnostic value of minimum apparent diffusion coefficient. AJNR Am J Neuroradiol, 2008, 29(10): 1872-1877.
[11]
钱银锋,殷敏敏,余永强.扩散加权成像在低级别胶质瘤的鉴别诊断价值.磁共振成像, 2010, 1(1):19-22.
[12]
Holodny AI, Makeyev S,Beattie BJ, et al. Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging. AJNR Am J Neuroradiol, 2010, 31(6):1042-1048.
[13]
Jenkinson MD, du Plessis DG, Smith TS, et al. Cellularity and apparent diffusion coefficient in oligodendroglial tumors characterized by genotype. J Neurooncol, 2010, 96(3):385-392.
[14]
Park MJ, Kim HS, Jahng GH, et al. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted Imaging in Patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol, 2009,30(7): 1402-1408.
[15]
Hori M, Mori H, Aoki S, et al. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas. Magn Reson Imaging, 2010, 28(4):594-598.
[16]
Wu Z, Mittal S, Kish K, et al. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging, 2009,29(1):177-182.
[17]
Dorozhkin SV, Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed Engl, 2002,41(17):3130-3136.
[18]
Xu M, See SJ, Ng WH, et al. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery, 2005, 56(5):919-926.
[19]
Krouwer HGJ, van Duinen SG, Kamphorst W, et al. Oligoastrocytomas: a clinicopathological study of 52 cases. J Neurooncol, 1997, 33(3):223-238.
[20]
van den Bent MJ. Anaplastic Oligodendroglioma and Oligoastrocytoma. Neurol Clin, 2007, 25(4):1089-1109.
[21]
Reifenberger G, Kros J, Burger P, et al. World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system. Lyon, France: IARC Press, 2000:56-69.
[22]
Shaw EG, Scheithauer BW, O' Fallon JR, et al. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg, 1992, 76(3):428-434.
[23]
Bauman GS, Cairncross JG. Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligoastrocytomas. Semin Radiat Oncol, 2001, 11(2):170-180.
[24]
Shaw EG, Scheithauer BW, O' Fallon JR, et al. Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery, 1994, 34(4):577-582.
[25]
Jenkinson MD, Smith TS, Brodbelt AR, et al. Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging, 2007, 26(6): 1405-1412.
[26]
Aldape K, Burger PC, Perry A. Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma. Arch Pathol Lab Med, 2007, 131(2): 242-251.
[27]
Jenkinson MD, du Plessis DG, Smith TS, et al. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain, 2006, 129(7): 1884-1891.
[28]
Wu A, Aldape K, Lang FF. High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors. J Neurooncol, 2010, 99(1):57-64.
[29]
Jenkinson MD, Smith TS, Joyce K, et al. MRS of oligodendroglial tumors Correlation with histopathology and genetic subtypes. Neurology, 2005, 64(12):2085-2089.
[30]
Jenkinson MD, Smith TS, Joyce KA, et al. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumors. Neuroradiology, 2006, 48(10):703-713.
[31]
Whitmore RG, Krejza J, Kapoor GS, et al. Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging. J Neurosurg, 2007, 107(3): 600-609.
[32]
Kapoor GS, Gocke TA, Chawla S, et al. Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status. J Neurooncol, 2009, 92(3):373-386.
[33]
Emblem KE, Scheie D, Due-Tonnessen P, et al. Histogram analysis of MR Imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am J Neuroradiol, 2008, 29(9): 1664-1670.
[34]
Chaichana KL, McGirt MJ, Niranjan A,et al. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature. Neurol Res, 2009,31(9): 931-939.
[35]
Choi KY,Jung TY,Jung S, et al. Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion. J Neurooncol, 2010, DOI: 10.1007/s11060-010-0353-z.
[36]
Jiang Z, LeBas JF, Grand S，et al. Prognostic value of perfusion MR imaging in patients with oligodendroglioma: A survival study. Journal of Neuroradiology, 2010, DOI: 10.1016/j.neurad.2010.03.004.
[37]
Murakami R, Sugahara T, Nakamura H, et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitive diffusion-weighted MR imaging. Radiology, 2007, 243(2):493-499.
[38]
Unal E, Koksal Y,Cimen O, et al. Malignant glioblastomatous transformation of a low-grade glioma in a child. Childs Nerv Syst, 2008, 24(12):1385-1389.
[39]
Weber MA, Giesel FL, Stieltjes B. MRI for identification of progression in brain tumors:from morphology to function. Expert Rev Neurother, 2008, 8(10):1507-1525.
[40]
Caseiras GB, Chheang S, Babb J, et al. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. European Journal of Radiology, 2010, 73(2):215-220.
[41]
Hlaihel C, Guilloton L,Guyotat J, et al. Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. J Neurooncol, 2010, 97(1):73-80.

PREV MR imaging in orbital tumors and simulating lesions
NEXT Latest technology on articular cartilage MR imaging: MapIt
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn